McGilvray and colleagues corroborated the poor prognosis in ovarian cancer using a larger cohort of patients where expression of high levels of ULBP-1-5 correlated with decreased survival, whereas MICA expression did not correlate with disease progression (43). This evidence concerns the gene MICA and ovarian carcinoma.